welbournes

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Tegretol® (carbamazepine) 100mg tablets. MSN/2023/074 Tier 2 – medium impact Date of issue 31st July 2023 Tegretol® (carbamazepine) 100mg tablets will be out of stock during August 2023 Tegretol® 200mg tablets and Tegretol® 100mg/5ml liquid remain available and will be able [...]

The post Medicine Supply Notification: Tegretol® (carbamazepine) 100mg tablets appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Reboxetine (Edronax®) 4mg tablets. MSN/2023/073 Tier 2 – medium impact Date of issue 31st July 2023 Reboxetine (Edronax®) 4mg tablets are out of stock from mid-August until the end of October 2023. Unlicensed imported stock is available (see details below) If [...]

The post Medicine Supply Notification: Reboxetine (Edronax®) 4mg tablets appeared first on Community Pharmacy England.

Following representations by Community Pharmacy England on behalf of pharmacies, the Department of Health and Social Care (DHSC) has redetermined the reimbursement prices for Jext and Priadel preparations for July 2023 to reflect an increase in their NHS list price. On 1st July 2023 the list prices for Jext preparations were increased by the manufacturer [...]

The post Jext and Priadel reimbursement prices redetermined for July 2023 appeared first on Community Pharmacy England.

National Patient Safety Alert: Potent synthetic opioids implicated in heroin overdoses and deaths National Patient Safety Alert Reference Number: NatPSA/2023/009/OHID Date issued: 26th July 2023 Brief description of the problem In the past 8 weeks there has been an elevated number of overdoses (with some deaths) in people who use drugs, primarily heroin, in many [...]

The post National Patient Safety Alert: Potent synthetic opioids implicated in heroin overdoses and deaths appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 12 July 2023) has been published and includes articles on: Hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch): risk of anticholinergic side effects, including hyperthermia. Codeine linctus: public consultation on the proposal to reclassify to a prescription-only medicine. [...]

The post MHRA Drug Safety Update July 2023 appeared first on Community Pharmacy England.